In 2005 KORHISPANA was acquired by the (Laboratorios Serra Pamies) LSP group and since then form a perfect team in the marketing of pharmaceuticals and medical products.
In 1995, KORHISPANA obtained the authorisation as Pharmaceutical Laboratory from the Spanish Ministry of Health. From that year, KORHISPANA has increased its activities with the launch of new pharmaceutical specialities.
Pioneers in 2002 with the launch to the market of Generic Pharmaceutical Specialities, KORHISPANA obtained the first generic speciality based on Ketoconazole (KETOCONAZOLE KORHISPANA 2% GEL EFG).
Currently Laboratorios KORHISPANA owns a broad portfolio of Generic Specialities and OTC's.
In November 2005, LABORATORIOS SERRA PAMIES acquires the totality of the capital. Both companies benefit, from that moment, of the corporative synergies and share future company projects.
The target of KORHISPANA is to lead the Spanish market of generic specialities, thanks to its portfolio and service, as well as to dedicate its efforts to the development of products for the health care and life quality of people.